JPRN-UMIN000000678CompletedPhase 2
Clinical Pharmacology Study of Z-206 - Study on Drug Concentration in Mucous Membrane of Z-206 in Healthy Male Adults- - Clinical Pharmacology Study of Z-206 -Study on Drug Concentration in Mucous Membrane of Z-206 in Healthy Male Adults
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 50years-old (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Subjects with hypersensitivity to drugs, drug dependency, or alcohol dependency or history of such 2)Subjects currently suffering from impediments of the digestive organs, disorders of the liver, renal disorders, hematological disorders, circulatory system diseases, mental or nervous disorders, etc., which are considered to be inappropriate for the participation in trial or history of such 3)Subjects with HBs antigen, HCV antibody, HIV antigen antibody, and positive syphilis serum test 4)Subjects taking a drug(s) within 1 week of the administration of the trial drug 5)Subjects receiving administration of any trial drug within 4 months prior to the trial drug administration 6)Subjects who received whole blood collection of 200 mL within 1 month before the trial drug administration or component blood collection within 2 weeks or blood collection of 400 mL or more (such as blood donation) within 3 months 7)Others, subjects judged by the principal investigator or co-investigators to be inappropriate for participation in this drug trial
Investigators
Similar Trials
Unknown
Unknown
Clinical Pharmacology Study of Z-100 - Study on Immunological Parameter in Healthy AdultJPRN-jRCT2080221848Zeria Pharmaceutical Co., Ltd.120
Completed
Phase 3
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
Unknown
Phase 3
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-jRCT2080220189Zeria Pharmaceutical Co., Ltd.
Completed
Phase 3
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phasePatients with ulcerative colitis in remission phase.JPRN-C000000289Zeria Pharmaceutical Co.,LTD.120
Unknown
Phase 3
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phasePatients with ulcerative colitis in active phaseJPRN-jRCT2080220176ZERIA Pharmaceutical Co.,Ltd.